Published in J Neurosci on August 13, 2008
Cellular strategies for controlling protein aggregation. Nat Rev Mol Cell Biol (2010) 3.54
p62/SQSTM1 cooperates with Parkin for perinuclear clustering of depolarized mitochondria. Genes Cells (2010) 2.91
Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. Nat Rev Drug Discov (2010) 2.90
Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synuclein. J Neurosci (2011) 2.53
Activation of specific apoptotic caspases with an engineered small-molecule-activated protease. Cell (2010) 1.85
Exploring the link between glucocerebrosidase mutations and parkinsonism. Trends Mol Med (2011) 1.71
Assembly, structure, and function of the 26S proteasome. Trends Cell Biol (2010) 1.61
The cellular pathways of neuronal autophagy and their implication in neurodegenerative diseases. Biochim Biophys Acta (2009) 1.56
Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy. Brain (2012) 1.55
Regulation of proteasome activity in health and disease. Biochim Biophys Acta (2013) 1.52
Integration of clearance mechanisms: the proteasome and autophagy. Cold Spring Harb Perspect Biol (2010) 1.52
Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies. Circulation (2010) 1.49
Polyubiquitin linkage profiles in three models of proteolytic stress suggest the etiology of Alzheimer disease. J Biol Chem (2011) 1.48
Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease. Br J Pharmacol (2011) 1.39
The ubiquitin-proteasome system in cardiac proteinopathy: a quality control perspective. Cardiovasc Res (2009) 1.36
Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Exp Mol Med (2015) 1.29
Recent advances in our understanding of neurodegeneration. J Neural Transm (Vienna) (2009) 1.27
Functional alterations of the ubiquitin-proteasome system in motor neurons of a mouse model of familial amyotrophic lateral sclerosis. Hum Mol Genet (2008) 1.24
Characterization of the Brain 26S Proteasome and its Interacting Proteins. Front Mol Neurosci (2010) 1.19
Ageing and Parkinson's disease: why is advancing age the biggest risk factor? Ageing Res Rev (2014) 1.17
Molecular chaperone-mediated rescue of mitophagy by a Parkin RING1 domain mutant. Hum Mol Genet (2010) 1.15
Motor neuron-specific disruption of proteasomes, but not autophagy, replicates amyotrophic lateral sclerosis. J Biol Chem (2012) 1.15
PINK1 function in health and disease. EMBO Mol Med (2009) 1.14
α-Synuclein fate is determined by USP9X-regulated monoubiquitination. Proc Natl Acad Sci U S A (2011) 1.13
Misfolded PrP impairs the UPS by interaction with the 20S proteasome and inhibition of substrate entry. EMBO J (2011) 1.13
The elimination of accumulated and aggregated proteins: a role for aggrephagy in neurodegeneration. Neurobiol Dis (2010) 1.12
Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in nondiabetics). Aging Cell (2011) 1.12
Protein degradation pathways in Parkinson's disease: curse or blessing. Acta Neuropathol (2012) 1.07
Phosphorylated alpha-synuclein at Ser-129 is targeted to the proteasome pathway in a ubiquitin-independent manner. J Biol Chem (2010) 1.07
A critical evaluation of the ubiquitin-proteasome system in Parkinson's disease. Biochim Biophys Acta (2009) 1.02
Proteasome dysfunction activates autophagy and the Keap1-Nrf2 pathway. J Biol Chem (2014) 1.01
Role of ubiquitin-proteasome-mediated proteolysis in nervous system disease. Biochim Biophys Acta (2010) 1.01
Granulovacuolar degeneration (GVD) bodies of Alzheimer's disease (AD) resemble late-stage autophagic organelles. Neuropathol Appl Neurobiol (2011) 0.97
Role of protein misfolding and proteostasis deficiency in protein misfolding diseases and aging. Int J Cell Biol (2013) 0.97
The ubiquitin-proteasome reporter GFPu does not accumulate in neurons of the R6/2 transgenic mouse model of Huntington's disease. PLoS One (2009) 0.97
The ubiquitin proteasome system in glia and its role in neurodegenerative diseases. Front Mol Neurosci (2014) 0.96
Investigating bacterial sources of toxicity as an environmental contributor to dopaminergic neurodegeneration. PLoS One (2009) 0.95
Mitochondrial dysfunction in Parkinson's disease. Parkinsons Dis (2011) 0.93
Interplay between the ubiquitin-proteasome system and autophagy in proteinopathies. Int J Physiol Pathophysiol Pharmacol (2009) 0.92
Perturbing the ubiquitin pathway reveals how mitosis is hijacked to denucleate and regulate cell proliferation and differentiation in vivo. PLoS One (2010) 0.92
Dendritic spinopathy in transgenic mice expressing ALS/dementia-linked mutant UBQLN2. Proc Natl Acad Sci U S A (2014) 0.91
∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. Nature (2015) 0.90
The impact of genetic research on our understanding of Parkinson's disease. Prog Brain Res (2010) 0.90
Genetics of proteasome diseases. Scientifica (Cairo) (2013) 0.90
Aging is not associated with proteasome impairment in UPS reporter mice. PLoS One (2009) 0.88
Genetically engineered mouse models of Parkinson's disease. Brain Res Bull (2011) 0.86
Molecular events underlying Parkinson's disease - an interwoven tapestry. Front Neurol (2013) 0.86
Lifespan of mice and primates correlates with immunoproteasome expression. J Clin Invest (2015) 0.86
Accelerated formation of alpha-synuclein oligomers by concerted action of the 20S proteasome and familial Parkinson mutations. J Bioenerg Biomembr (2010) 0.84
Aggregate clearance of α-synuclein in Saccharomyces cerevisiae depends more on autophagosome and vacuole function than on the proteasome. J Biol Chem (2012) 0.84
Misfolded PrP and a novel mechanism of proteasome inhibition. Prion (2012) 0.83
Quality control systems in cardiac aging. Ageing Res Rev (2015) 0.83
Protein degradation systems in platelets. Thromb Haemost (2013) 0.83
Genetics of aging, health, and survival: dynamic regulation of human longevity related traits. Front Genet (2015) 0.82
Coordination between proteasome impairment and caspase activation leading to TAU pathology: neuroprotection by cAMP. Cell Death Dis (2012) 0.82
Modelling the role of UCH-L1 on protein aggregation in age-related neurodegeneration. PLoS One (2010) 0.82
Postnatal proteasome inhibition induces neurodegeneration and cognitive deficiencies in adult mice: a new model of neurodevelopment syndrome. PLoS One (2011) 0.82
Pale body-like inclusion formation and neurodegeneration following depletion of 26S proteasomes in mouse brain neurones are independent of α-synuclein. PLoS One (2013) 0.81
Charcot-Marie-Tooth disease and intracellular traffic. Prog Neurobiol (2012) 0.81
Unraveling the message: insights into comparative genomics of the naked mole-rat. Mamm Genome (2016) 0.80
Experimental and computational analysis of polyglutamine-mediated cytotoxicity. PLoS Comput Biol (2010) 0.80
Biochemical and pathological correlates of cognitive and behavioural change in DLB/PDD. J Neurol (2009) 0.79
Activation of proteasome by insulin-like growth factor-I may enhance clearance of oxidized proteins in the brain. Mech Ageing Dev (2009) 0.79
Proteasome dysfunction induces muscle growth defects and protein aggregation. J Cell Sci (2014) 0.79
Phosphorylation of serine 349 of p62 in Alzheimer's disease brain. Acta Neuropathol Commun (2014) 0.79
Proteasome inhibition leads to early loss of synaptic proteins in neuronal culture. J Neural Transm (Vienna) (2012) 0.78
Prion degradation pathways: Potential for therapeutic intervention. Mol Cell Neurosci (2015) 0.78
Protein recycling pathways in neurodegenerative diseases. Alzheimers Res Ther (2014) 0.77
Models of α-synuclein aggregation in Parkinson's disease. Acta Neuropathol Commun (2014) 0.77
The Proteasome Inhibition Model of Parkinson's disease. J Parkinsons Dis (2016) 0.76
Misfolded proteins driven to destruction by Hul5. Nat Cell Biol (2011) 0.76
Medaka fish Parkinson's disease model. Exp Neurobiol (2012) 0.75
Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism-like phenotype in mice. EMBO J (2016) 0.75
Genome wide association study identifies variants in NBEA associated with migraine in bipolar disorder. J Affect Disord (2014) 0.75
The role of autophagy in Parkinson's disease. Neural Regen Res (2012) 0.75
Morphological Changes within the Rat Lateral Ventricle after the Administration of Proteasome Inhibitors. PLoS One (2015) 0.75
The Proteasome and Oxidative Stress in Alzheimer's Disease. Antioxid Redox Signal (2016) 0.75
Ubiquitin and Parkinson's disease through the looking glass of genetics. Biochem J (2017) 0.75
TOPORS, a Dual E3 Ubiquitin and Sumo1 Ligase, Interacts with 26 S Protease Regulatory Subunit 4, Encoded by the PSMC1 Gene. PLoS One (2016) 0.75
Coordinate regulation of autophagy and the ubiquitin proteasome system by MTOR. Autophagy (2016) 0.75
G2019S LRRK2 and aging confer susceptibility to proteasome inhibitor-induced neurotoxicity in nigrostriatal dopaminergic system. J Neural Transm (Vienna) (2015) 0.75
Continued 26S proteasome dysfunction in mouse brain cortical neurons impairs autophagy and the Keap1-Nrf2 oxidative defence pathway. Cell Death Dis (2017) 0.75
Proteasome impairment by α-synuclein. PLoS One (2017) 0.75
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J Clin Oncol (2010) 4.94
Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nat Rev Mol Cell Biol (2005) 4.88
Human corneal anatomy redefined: a novel pre-Descemet's layer (Dua's layer). Ophthalmology (2013) 3.75
Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. Nat Rev Drug Discov (2010) 2.90
Schwann cell precursors from nerve innervation are a cellular origin of melanocytes in skin. Cell (2009) 2.53
Multiple reassortment between pandemic (H1N1) 2009 and endemic influenza viruses in pigs, United States. Emerg Infect Dis (2011) 2.42
Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI. Neurology (2013) 2.35
Role of transportation in spread of porcine epidemic diarrhea virus infection, United States. Emerg Infect Dis (2014) 2.23
Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas. Neuro Oncol (2010) 2.01
Transgenic expression of Cre recombinase from the tyrosine hydroxylase locus. Genesis (2004) 1.99
The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53. Cancer Cell (2005) 1.90
Proteasomal degradation of tau protein. J Neurochem (2002) 1.88
Assessing the accuracy of Orbscan II post-LASIK: apparent keratectasia is paradoxically associated with anterior chamber depth reduction in successful procedures. Clin Experiment Ophthalmol (2005) 1.83
Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers. J Virol (2003) 1.79
Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study. PLoS Med (2009) 1.72
Acute lung injury and cell death: how many ways can cells die? Am J Physiol Lung Cell Mol Physiol (2008) 1.69
Ubiquitin recognition by the ubiquitin-associated domain of p62 involves a novel conformational switch. J Biol Chem (2007) 1.68
Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Res (2009) 1.63
Clinical and biological significance of E-cadherin protein expression in invasive lobular carcinoma of the breast. Am J Surg Pathol (2010) 1.63
Assembly, structure, and function of the 26S proteasome. Trends Cell Biol (2010) 1.61
Histological and confocal microscopy changes in chronic corneal edema: implications for endothelial transplantation. Invest Ophthalmol Vis Sci (2011) 1.50
Alcohol debridement of the corneal epithelium in PRK and LASEK: an electron microscopic study. Invest Ophthalmol Vis Sci (2003) 1.50
Acanthamoeba keratitis: the role of domestic tap water contamination in the United Kingdom. Invest Ophthalmol Vis Sci (2004) 1.50
Alcohol delamination of the corneal epithelium: an alternative in the management of recurrent corneal erosions. Ophthalmology (2006) 1.49
Enterobacter sakazakii invades brain capillary endothelial cells, persists in human macrophages influencing cytokine secretion and induces severe brain pathology in the neonatal rat. Microbiology (2007) 1.49
Physical and functional interaction of sequestosome 1 with Keap1 regulates the Keap1-Nrf2 cell defense pathway. J Biol Chem (2010) 1.47
Rapid tyrosine phosphorylation of neuronal proteins including tau and focal adhesion kinase in response to amyloid-beta peptide exposure: involvement of Src family protein kinases. J Neurosci (2002) 1.46
Oligodendrocytes promote neuronal survival and axonal length by distinct intracellular mechanisms: a novel role for oligodendrocyte-derived glial cell line-derived neurotrophic factor. J Neurosci (2003) 1.45
Global democratic consensus on neuropathological disease criteria. Lancet Neurol (2002) 1.44
Analysis of nondegradative protein ubiquitylation with a monoclonal antibody specific for lysine-63-linked polyubiquitin. Proc Natl Acad Sci U S A (2008) 1.42
Task Manager: an innovative approach to improving hospital communication after hours. N Z Med J (2010) 1.40
A free community approach to classifying disease. PLoS Med (2004) 1.40
Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases. J Biol Chem (2008) 1.38
Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma. Neuro Oncol (2008) 1.33
Distinct cellular patterns of upregulated chemokine expression supporting a prominent inflammatory role in traumatic brain injury. J Neurotrauma (2008) 1.30
Pediatric ependymoma: biological perspectives. Mol Cancer Res (2009) 1.29
The stem cell marker CD133 associates with enhanced colony formation and cell motility in colorectal cancer. PLoS One (2010) 1.24
Structure of the ubiquitin-associated domain of p62 (SQSTM1) and implications for mutations that cause Paget's disease of bone. J Biol Chem (2003) 1.24
PPARdelta agonism induces a change in fuel metabolism and activation of an atrophy programme, but does not impair mitochondrial function in rat skeletal muscle. J Physiol (2007) 1.23
Loss of ubiquitin-binding associated with Paget's disease of bone p62 (SQSTM1) mutations. J Bone Miner Res (2004) 1.23
Gankyrin is an ankyrin-repeat oncoprotein that interacts with CDK4 kinase and the S6 ATPase of the 26 S proteasome. J Biol Chem (2002) 1.18
Gankyrin: a new oncoprotein and regulator of pRb and p53. Trends Cell Biol (2006) 1.17
The early responses of VEGF and its receptors during acute lung injury: implication of VEGF in alveolar epithelial cell survival. Crit Care (2006) 1.17
The evolutionary history and tissue mapping of amino acid transporters belonging to solute carrier families SLC32, SLC36, and SLC38. J Mol Neurosci (2008) 1.16
Morphological characteristics of the limbal epithelial crypt. Br J Ophthalmol (2006) 1.16
Conditional knockout of the Smad1 gene. Genesis (2002) 1.16
Architecture and distribution of human corneal nerves. Br J Ophthalmol (2009) 1.16
Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugs. Int J Oncol (2007) 1.15
MAGE-A4 interacts with the liver oncoprotein gankyrin and suppresses its tumorigenic activity. J Biol Chem (2003) 1.15
Dimerisation of the UBA domain of p62 inhibits ubiquitin binding and regulates NF-kappaB signalling. J Mol Biol (2009) 1.14
The crystal structure of gankyrin, an oncoprotein found in complexes with cyclin-dependent kinase 4, a 19 S proteasomal ATPase regulator, and the tumor suppressors Rb and p53. J Biol Chem (2003) 1.14
Neutralization of interleukin-1β reduces cerebral edema and tissue loss and improves late cognitive outcome following traumatic brain injury in mice. Eur J Neurosci (2011) 1.14
Spinal cord gray matter demyelination in multiple sclerosis-a novel pattern of residual plaque morphology. Brain Pathol (2006) 1.13
Human immunodeficiency virus-1 Tat protein interacts with distinct proteasomal alpha and beta subunits. FEBS Lett (2003) 1.12
A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice. Hum Mol Genet (2011) 1.12
DCD and ADHD: a genetic study of their shared aetiology. Hum Mov Sci (2006) 1.10
Differences in the vascular patterns of basal and squamous cell skin carcinomas explain their differences in clinical behaviour. J Pathol (2003) 1.10
Novel cell- and tissue-based assays for detecting misfolded and aggregated protein accumulation within aggresomes and inclusion bodies. Cell Biochem Biophys (2011) 1.10
Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastoma. Neuro Oncol (2011) 1.10
Osteonecrosis of the jaw and bisphosphonates--putting the risk in perspective. N Z Med J (2006) 1.09
Novel UBA domain mutations of SQSTM1 in Paget's disease of bone: genotype phenotype correlation, functional analysis, and structural consequences. J Bone Miner Res (2004) 1.09
Intestinal ischemia-reperfusion-induced acute lung injury and oncotic cell death in multiple organs. Shock (2007) 1.08
C-terminal Tensin-like (CTEN) is an oncogene which alters cell motility possibly through repression of E-cadherin in colorectal cancer. J Pathol (2009) 1.07
Quick-multiplex-consensus (QMC)-PCR followed by high-resolution melting: a simple and robust method for mutation detection in formalin-fixed paraffin-embedded tissue. J Clin Pathol (2010) 1.06
Engulfing astrocytes protect neurons from contact-induced apoptosis following injury. PLoS One (2012) 1.06
Characterization of a non-UBA domain missense mutation of sequestosome 1 (SQSTM1) in Paget's disease of bone. J Bone Miner Res (2009) 1.05
Chromosome 16 tumor-suppressor genes in breast cancer. Genes Chromosomes Cancer (2006) 1.05
Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): Trial design. Contemp Clin Trials (2006) 1.05
Duplication of amyloid precursor protein (APP), but not prion protein (PRNP) gene is a significant cause of early onset dementia in a large UK series. Neurobiol Aging (2010) 1.04
The ubiquitin-proteasome system and neurodegenerative disorders. Essays Biochem (2005) 1.04
The relationship between motor coordination, executive functioning and attention in school aged children. Arch Clin Neuropsychol (2004) 1.03
Closed head injury in a mouse model results in molecular changes indicating inflammatory responses. J Neurotrauma (2009) 1.03
The oncoprotein gankyrin negatively regulates both p53 and RB by enhancing proteasomal degradation. Cell Cycle (2005) 1.02
Timing the doxycycline yields different patterns of genomic recombination in brain neurons with a new inducible Cre transgene. J Neurosci Res (2002) 1.01
Spinal cord neuronal pathology in multiple sclerosis. Brain Pathol (2008) 1.01
Annexins in human breast cancer: Possible predictors of pathological response to neoadjuvant chemotherapy. Eur J Cancer (2009) 1.00
Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain. Neuropharmacology (2006) 0.99
Histologic features of transplanted amniotic membrane: implications for corneal wound healing. Ophthalmology (2009) 0.99
The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity. Nat Cell Biol (2012) 0.99
Spinal cord atrophy in multiple sclerosis caused by white matter volume loss. Arch Neurol (2005) 0.98